secwatch.observer — SEC 8-K summary
======================================

Issuer:     MESA LABORATORIES INC /CO/ (MLAB)
CIK:        0000724004
Form:       8-K
Filed at:   2022-05-31T23:59:59+00:00
Accession:  0001437749-22-013842
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mesa Labs reports Q4 GAAP operating loss of $110k; adjusted op income ex-unusual items up 31%
--------------------------------------------------------------------------------

- GAAP operating loss of $110k vs income of $4.3M a year ago; net loss $1.78M (-$0.34 diluted EPS).
- Non-GAAP adjusted operating income (AOI) rose 11% to $11.65M; AOI ex-unusual items up 31% to $13.57M.
- Total revenues grew 55% in Q4 to $58.9M, organic +12%; FY revenues up 38% to $184.3M, organic +13%.
- Clinical Genomics segment revenue $16.4M including $1.4M COVID; ex-COVID below plan, China lockdowns expected to impact Q1.
- FY23 guidance cautious: lower organic growth expected due to inflation, war in Europe, and Asia pandemic resurgence.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/724004/000143774922013842/0001437749-22-013842-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/724004/000143774922013842/mlab20220528_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-013842

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer